Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Aug 1;168(2):795-800.
doi: 10.1084/jem.168.2.795.

Lymphokine production by murine T cells in the mixed leukocyte reaction

Affiliations

Lymphokine production by murine T cells in the mixed leukocyte reaction

E Puré et al. J Exp Med. .

Abstract

Although the production of B cell stimulatory factors by cell lines and hybridomas is well established, production of specific lymphokines by normal T cells in response to antigen stimulation has not been analyzed. We have used bioassays and neutralizing mAbs to demonstrate that IL-2, IL-4, and B cell growth factors (BCGF) are produced during primary and secondary MLRs. IL-2 is detected in the first 12 h of both types of MLR. IL-4 and BCGF appear at 24-48 h in the conditioned medium of the primary MLR, and peak by 12 h in the secondary MLR. The amount of IL-4 in the primary response reaches a level that is 10% of that detected in the secondary. In contrast, BCGF production steadily increases over time in the primary MLR, and maximal production is equivalent to that made in the secondary response. Allogeneic dendritic cells and anti-Ig-activated B blasts both stimulated lymphokine production in the primary MLR, whereas small B cells were weak. In the secondary MLR, all three cell populations stimulated the production of IL-2, IL-4, and BCGF. Therefore, the release of several defined B cell stimulating factors can be detected in the conditioned media of responding primary T lymphocytes.

PubMed Disclaimer

References

    1. J Exp Med. 1984 Mar 1;159(3):881-905 - PubMed
    1. J Exp Med. 1984 Dec 1;160(6):1717-35 - PubMed
    1. Nature. 1985 May 23-29;315(6017):333-6 - PubMed
    1. Proc Natl Acad Sci U S A. 1986 Jul;83(14):5228-32 - PubMed
    1. Annu Rev Immunol. 1988;6:485-512 - PubMed

Publication types